Deutsches Krebsforschungszentrum (DKFZ)

Mutation-induced alterations of intra-filament subunit organization in vimentin filaments revealed by SAXS (2019) Brennich ME, Vainio U, Wedig T, Bauch S, Herrmann H, Koester S Journal article Impact of radiation, systemic therapy and treatment sequencing on survival of patients with melanoma brain metastases (2019) Rauschenberg R, Bruns J, Bruetting J, Daubner D, Lohaus F, Zimmer L, Forschner A, et al. Journal article A five-microRNA signature predicts survival and disease control of patients with head and neck cancer negative for HPV infection (2019) Hess J, Unger K, Maihoefer C, Schuettrumpf L, Wintergerst L, Heider T, Weber P, et al. Journal article Chicken GRIFIN: binding partners, developmental course of localization and activation of its lens-specific gene expression by L-Maf/Pax6 (2019) Caballero GG, Schmidt S, Schnoelzer M, Schlötzer-Schrehardt U, Knospe C, Ludwig AK, Manning JC, et al. Journal article Sequence-dependent cross-resistance of combined radiotherapy plus BRAF(V600E) inhibition in melanoma (2019) Shannan B, Matschke J, Chauvistre H, Vogel F, Klein D, Meier F, Westphal D, et al. Journal article Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with FLT3-ITD (2019) Schlenk RF, Weber D, Fiedler W, Salih HR, Wulf G, Salwender H, Schroeder T, et al. Journal article Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial (2019) Herrlinger U, Tzaridis T, Mack F, Steinbach JP, Schlegel U, Sabel M, Hau P, et al. Journal article Efficacy and safety of everolimus plus exemestane in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative locally advanced or metastatic breast cancer: Results of the single-arm, phase IIIB 4EVER trial (2019) Tesch H, Stoetzer O, Decker T, Kurbacher CM, Marme F, Schneeweiss A, Mundhenke C, et al. Journal article The impact of mammalian target of rapamycin inhibition on bone health in postmenopausal women with hormone receptor-positive advanced breast cancer receiving everolimus plus exemestane in the phase IIIb 4EVER trial (2019) Hadji P, Stoetzer O, Decker T, Kurbacher CM, Marme F, Schneeweiss A, Mundhenke C, et al. Journal article Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk (2019) Yang Y, Wu L, Shu X, Lu Y, Shu XO, Cai Q, Beeghly-Fadiel A, et al. Journal article